Pulmonary Sarcoidosis: A Disease Characterized and Perpetuated by Activated Lung T-Lymphocytes

  1. RONALD G. CRYSTAL, M.D.;
  2. WILLIAM C. ROBERTS, M.D.;
  3. GARY W. HUNNINGHAKE, M.D.;
  4. JAMES E. GADEK, M.D.;
  5. JACK D. FULMER, M.D.; and
  6. BRUCE R. LINE, M.D.
  1. Bethesda, Maryland

    Abstract

    The alveolitis of pulmonary sarcoidosis is characterized by an intense, mononuclear cell infiltrate that probably precedes granuloma formation. Pathogenic mechanisms underlying pulmonary sarcoidosis can be shown by study of the mononuclear cells composing the alveolitis. Bronchoalveolar lavage has shown that the sarcoid lung is characterized by increased numbers of "activated" T-lymphocytes within the alveolar structures. In contrast to normal control cells, the lung T-lymphocytes of patients with sarcoid release the mediator, monocyte chemotactic factor, that probably contributes to the pathogenesis of sarcoidosis by recruiting blood monocytes to the lung, thus providing cellular building blocks for granuloma formation. Conventional monitors of the activity of pulmonary sarcoidosis, such as blood studies, pulmonary function testing, and chest roentgenograms, show little relation to the intensity of the T-lymphocyte alveolitis as assessed by bronchoalveolar lavage or by histopathologic studies. In contrast, quantification of lavage T-lymphocyte populations and 67Ga scintigraphy of the chest provide a sensitive and specific means of assessing the activity of the alveolitis in pulmonary sarcoidosis and may provide a rational basis for therapy.

    Article and Author Information

    • ▸An edited transcription of a Combined Clinical Staff Conference at the Clinical Center, Bethesda, Maryland, 29 June 1978, by the National Institutes of Health, U.S. Department of Health, Education, and Welfare.

    • ▸Authors who wish to cite a section of the conference and specifically indicate its author can use this example for the form of reference:

      ROBERTS WC. Morphologic aspects of pulmonary sarcoidosis, pp. 73-6. In: CRYSTAL RG, moderator. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med. 1981;94:73-94.

    • ▸Requests for reprints should be addressed to Ronald G. Crystal, M.D.; Building 10, Room 6D06, National Institutes of Health; Bethesda, MD 20205.

    « Previous | Next Article »Table of Contents